Long-term Prognosis of Patients With Sepsis After Immunotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

900

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions

Long-term Effects of Thymosin Alpha 1 Treatment

Interventions

DRUG

Thymosin Alpha1

Drug interventions have been done in previous clinical studies

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT04901104 - Long-term Prognosis of Patients With Sepsis After Immunotherapy | Biotech Hunter | Biotech Hunter